BioSpace News Archive

Numerous governments are increasingly investing in initiatives to spread awareness on health of women.

The presence of a resilient and growth-oriented healthcare sector has played an integral role in driving sales across the global hba1c analysers market.

Advances in neuroscience research pivot on relentless urge of researchers to understand relationships between neural structures, function, and behaviour.

Leading nonprofit marketing strategist and executive consultant Katrina McGhee has joined the American Heart Association’s nationwide leadership team as executive vice president of marketing and communications.

OTTAWA , Feb. 17, 2020 /CNW/ - Health Canada is advising Canadians that the following products may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert . Health Canada maintains a list of unauthorized health products that may pose serious health risks so that Canadians can easily identify those they may h

TRENTON, ON , Feb. 17, 2020 /CNW/ - February 18, 2020 The itinerary of events includes: Trenton, Ontario 10:00a.m. EST : Minister Hajdu will meet with staff from the Public Health Agency of Canada , Health Canada, Public Safety Canada, and the Ontario Emergency Medical Assistance Team, as well as members of the Canadian Armed Forces and volunteers f

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its fourth quarter and year-end 2019 financial results and provide an update on the company’s business and outlook on Monday, March 2, 2020 at 4:30 p.m. (ET) after the closing of the market.

Enexor BioEnergy (“Enexor”), an organic waste to energy company, announced the release of its on-site, small-scale plastics-to-energy technology – the PTE-200™ (“System”), which converts unrecyclable plastics into affordable clean energy (75kW power and 125kW thermal).

PRINCETON, N.J., Feb. 17, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immuno-oncology company developing multiple therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced that Dr. Frank Bedu-Addo, President and Chief Executive Officer and Dr. Lauren Wood, Chief Medical Officer are scheduled to participate in Noble Capital Markets’ 16 th Annual Small & Microcap Investor Conference being held on Februar

ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and year-end 2019 financial results on Thursday, February 20, 2020, before the U.S. financial markets open